Regulation of the C5a receptor promoter in glial cells: Minimal dependence upon the CCAAT element in astrocytes

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 713-721

  Martin, Carol B ^a   Ingersoll, Sarah A ^a   Martin, Brian K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

C5a receptor; CCAAT; Complement; Gene regulation; Rodent

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; BONE MARROW CELL; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM; GENE CONTROL; GLIA CELL; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TRANSFORMED; MICE; MICROGLIA; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RECEPTOR, ANAPHYLATOXIN C5A; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

RODENTIA;

EID: 33748794781     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.04.016     Document Type: Article

References (46)

1. Armstrong R.C., Harvath L., and Dubois-Dalcq M.E. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 27 (1990) 400-407
2. Barnum S.R. Complement in central nervous system inflammation. Immunol. Res. 26 (2002) 7-13
3. Benard M., Gonzalez B.J., Schouft M.T., Falluel-Morel A., Vaudry D., Chan P., Vaudry H., and Fontaine M. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation: neuroprotective effect of C5a against apoptotic cell death. J. Biol. Chem. 2 (2004) 2
4. Blackwell T.S., and Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell. Mol. Biol. 17 (1997) 3-9
5. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212 (1990) 563-578
6. Chao C.C., Hu S., Shark K.B., Sheng W.S., Gekker G., and Peterson P.K. Activation of mu opioid receptors inhibits microglial cell chemotaxis. J. Pharmacol. Exp. Ther. 281 (1997) 998-1004
7. Davoust N., Jones J., Stahel P.F., Ames R.S., and Barnum S.R. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 26 (1999) 201-211
8. Dube V.E., McDuffie F.C., Burton R.C., and Ilstrup D. Cerebrospinal fluid complement in multiple sclerosis. J. Lab. Clin. Med. 81 (1973) 530-537
9. Farkas I., Baranyi L., Liposits Z.S., Yamamoto T., and Okada H. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells. Neuroscience 86 (1998) 903-911
10. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Z., Yamamoto T., and Okada H. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507 (1998) 679-687
11. Farkas I., Takahashi M., Fukuda A., Yamamoto N., Akatsu H., Baranyi L., Tateyama H., Yamamoto T., Okada N., and Okada H. Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease. J. Immunol. 170 (2003) 5764-5771
12. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Gotze O., and Morgan B.P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155 (1995) 4882-4889
13. Gasque P., Singhrao S.K., Neal J.W., Gotze O., and Morgan B.P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150 (1997) 31-41
14. Gasque P., Singhrao S.K., Neal J.W., Wang P., Sayah S., Fontaine M., and Morgan B.P. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J. Immunol. 160 (1998) 3543-3554
15. Gentles A.J., and Karlin S. Why are human G-protein-coupled receptors predominantly intronless?. Trends Genet. 15 (1999) 47-49
16. Gerard C., and Gerard N.P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12 (1994) 775-808
17. Gerard N.P., Bao L., Xiao-Ping H., Eddy Jr. R.L., Shows T.B., and Gerard C. Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene. Biochemistry 32 (1993) 1243-1250
18. Guo R.F., and Ward P.A. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 23 (2005) 821-852
19. Haviland D.L., McCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., and Wetsel R.A. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154 (1995) 1861-1869
20. Hunt J.R., Martin C.B., and Martin B.K. Transcriptional regulation of the murine C5a receptor gene: NF-Y is required for basal and LPS induced expression in macrophages and endothelial cells. Mol. Immunol. 42 (2005) 1405-1415 (pub February 12, 2005)
21. Kim S.U., and de Vellis J. Microglia in health and disease. J. Neurosci. Res. 81 (2005) 302-313
22. Lacy M., Jones J., Whittemore S.R., Haviland D.L., Wetsel R.A., and Barnum S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61 (1995) 71-78
23. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucl. Acids Res. 26 (1998) 1135-1143
24. Martin C.B., and Martin B.K. Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like site. J. Immunol. 175 (2005) 3123-3132
25. McCarthy K.D., and de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85 (1980) 890-902
26. Morgan B.P., Gasque P., Singhrao S., and Piddlesden S.J. The role of complement in disorders of the nervous system. Immunopharmacology 38 (1997) 43-50
27. Mukherjee P., and Pasinetti G.M. The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease. J. Neuroimmunol. 105 (2000) 124-130
28. Mukherjee P., and Pasinetti G.M. Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J. Neurochem. 77 (2001) 43-49
29. Muller-Ladner U., Jones J.L., Wetsel R.A., Gay S., Raine C.S., and Barnum S.R. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144 (1996) 135-141
30. Nataf S., Levison S.W., and Barnum S.R. Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage. Brain Res. 894 (2001) 321-326
31. Nataf S., Stahel P.F., Davoust N., and Barnum S.R. Complement anaphylatoxin receptors on neurons: new tricks for old receptors?. Trends Neurosci. 22 (1999) 397-402
32. Nikcevich K.M., Piskurich J.F., Hellendall R.P., Wang Y., and Ting J.P. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha. J. Neuroimmunol. 99 (1999) 195-204
33. Nolte C., Moller T., Walter T., and Kettenmann H. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience 73 (1996) 1091-1107
34. Osaka H., Mukherjee P., Aisen P.S., and Pasinetti G.M. Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J. Cell. Biochem. 73 (1999) 303-311
35. Reiman R., Gerard C., Campbell I.L., and Barnum S.R. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis. Eur. J. Immunol. 32 (2002) 1157-1163
36. Reiman R., Torres A.C., Martin B.K., Ting J.P., Campbell I.L., and Barnum S.R. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis. Neurosci. Lett. 8 (2005) 8
37. Soos J.M., Morrow J., Ashley T.A., Szente B.E., Bikoff E.K., and Zamvil S.S. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J. Immunol. 161 (1998) 5959-5966
38. Stahel P.F., and Barnum S.R. Bacterial meningitis: complement gene expression in the central nervous system. Immunopharmacology 38 (1997) 65-72
39. Stahel P.F., Frei K., Eugster H.P., Fontana A., Hummel K.M., Wetsel R.A., Ames R.S., and Barnum S.R. TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J. Immunol. 159 (1997) 861-869
40. Stahel P.F., Kossmann T., Morganti-Kossmann M.C., Hans V.H., and Barnum S.R. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Brain Res. Mol. 50 (1997) 205-212
41. Van Beek J., Bernaudin M., Petit E., Gasque P., Nouvelot A., MacKenzie E.T., and Fontaine M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161 (2000) 373-382
42. Van Beek J., Elward K., and Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N.Y. Acad. Sci. 992 (2003) 56-71
43. Wetsel R.A. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Immunol. Lett. 44 (1995) 183-187
44. Wetsel R.A. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7 (1995) 48-53
45. Yao J., Harvath L., Gilbert D.L., and Colton C.A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27 (1990) 36-42
46. Zwirner J., Fayyazi A., and Gotze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol. Immunol. 36 (1999) 877-884